D. E. Shaw & Co., Inc. Agenus Inc Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.53 - $0.93 $126,979 - $222,813	239,584 Added 7.88%	3,279,715 $1.9 Million
Q4 2023 Feb 14, 2024	BUY	$0.63 - $1.14 $1.92 Million - $3.47 Million	3,040,131 New	3,040,131 $2.52 Million
Q1 2023 May 15, 2023	SELL	$1.45 - $2.95 $1.13 Million - $2.31 Million	-782,520 Reduced 72.95%	290,103 $440,000
Q4 2022 Feb 14, 2023	SELL	$2.02 - $3.25 $871,642 - $1.4 Million	-431,506 Reduced 28.69%	1,072,623 $2.57 Million
Q3 2022 Nov 14, 2022	SELL	$1.96 - $3.14 $1.34 Million - $2.14 Million	-681,874 Reduced 31.19%	1,504,129 $3.08 Million
Q2 2022 Aug 15, 2022	SELL	$1.3 - $2.64 $1.07 Million - $2.17 Million	-822,667 Reduced 27.34%	2,186,003 $4.24 Million
Q1 2022 May 16, 2022	SELL	$2.35 - $3.47 $4.69 Million - $6.93 Million	-1,997,304 Reduced 39.9%	3,008,670 $7.4 Million
Q4 2021 Feb 14, 2022	BUY	$2.92 - $5.74 $5.69 Million - $11.2 Million	1,950,325 Added 63.83%	5,005,974 $16.1 Million
Q3 2021 Nov 15, 2021	BUY	$4.98 - $6.63 $9.46 Million - $12.6 Million	1,899,244 Added 164.24%	3,055,649 $16 Million
Q2 2021 Aug 16, 2021	SELL	$2.56 - $5.49 $219,811 - $471,393	-85,864 Reduced 6.91%	1,156,405 $6.35 Million
Q1 2021 May 17, 2021	SELL	$2.69 - $5.25 $94,144 - $183,739	-34,998 Reduced 2.74%	1,242,269 $3.38 Million
Q4 2020 Feb 16, 2021	BUY	$3.17 - $4.49 $3.2 Million - $4.54 Million	1,010,384 Added 378.59%	1,277,267 $4.06 Million
Q3 2020 Nov 16, 2020	SELL	$2.98 - $5.2 $1.11 Million - $1.93 Million	-371,982 Reduced 58.23%	266,883 $1.07 Million
Q2 2020 Aug 14, 2020	SELL	$2.29 - $4.24 $2.4 Million - $4.45 Million	-1,048,915 Reduced 62.15%	638,865 $2.51 Million
Q1 2020 May 15, 2020	SELL	$1.92 - $4.39 $453,129 - $1.04 Million	-236,005 Reduced 12.27%	1,687,780 $4.14 Million
Q4 2019 Feb 14, 2020	BUY	$2.41 - $4.4 $275,506 - $502,999	114,318 Added 6.32%	1,923,785 $7.83 Million
Q3 2019 Nov 14, 2019	SELL	$2.17 - $3.14 $2.53 Million - $3.66 Million	-1,164,321 Reduced 39.15%	1,809,467 $4.67 Million
Q2 2019 Aug 14, 2019	SELL	$2.53 - $3.04 $2.05 Million - $2.46 Million	-810,778 Reduced 21.42%	2,973,788 $8.92 Million
Q1 2019 May 15, 2019	BUY	$2.51 - $3.73 $3.28 Million - $4.88 Million	1,306,981 Added 52.75%	3,784,566 $11.2 Million
Q4 2018 Feb 14, 2019	BUY	$1.59 - $2.66 $656,159 - $1.1 Million	412,679 Added 19.99%	2,477,585 $5.9 Million
Q3 2018 Nov 14, 2018	SELL	$1.59 - $2.42 $324,668 - $494,149	-204,194 Reduced 9.0%	2,064,906 $4.42 Million
Q2 2018 Aug 14, 2018	BUY	$2.26 - $4.65 $1.01 Million - $2.08 Million	448,006 Added 24.6%	2,269,100 $5.15 Million
Q1 2018 May 15, 2018	BUY	$3.51 - $6.04 $4.24 Million - $7.29 Million	1,207,475 Added 196.78%	1,821,094 $8.58 Million
Q4 2017 Feb 14, 2018	BUY	$3.26 - $4.78 $1.4 Million - $2.06 Million	430,369 Added 234.85%	613,619 $2 Million
Q3 2017 Nov 14, 2017	BUY	$3.48 - $4.44 $637,710 - $813,630	183,250	183,250 $808,000

Others Institutions Holding AGEN

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

View Full List

About AGENUS INC

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

More about AGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account